Your session is about to expire
← Back to Search
MANTA Vascular Closure Device for Femoral Artery Closure (MANTA ULTRA Trial)
MANTA ULTRA Trial Summary
This trial demonstrates the safety of the MANTA Vascular Closure Device, which uses ultrasound to guide closure of the femoral artery, in patients undergoing elective TAVR procedures.
MANTA ULTRA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MANTA ULTRA Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is today's patient recruitment goal for this research project?
"The sponsor, Teleflex, needs to enroll 180 eligible patients from various clinical trial sites - including Washington Hospital Center in Washington, District of Columbia and Sentara Northern Virginia Medical Center in Woodbridge, Virginia - in order to complete the study."
If I'm interested in participating in this trial, how many different places can I go to?
"This study is being conducted in several hospitals, including Washington Hospital Center, Sentara Northern Virginia Medical Center, and University of Buffalo."
Are there any presently open vacancies for patients in this experiment?
"The trial is still recruiting patients, as indicated by the 8/24/2022 edit date on clinicaltrials.gov. The listing for this study was first posted on 8/9/2022."
Share this study with friends
Copy Link
Messenger